Press Releases

– NDA for etripamil in PSVT resubmitted in 1Q 2024– Cash resources as of March 31, 2024 expected to fund operations into 2026– Dialogue with FDA to finalize Phase 3 protocol for etripamil in AFib-RVR is progressing

MONTREAL and CHARLOTTE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the first quarter ended March 31, 2024 and provided a regulatory and corporate update.

... (continue reading...)

• Board Urges Shareholders to Vote “FOR” ALL of Gildan’s Recommended Qualified and Experienced Director Nominees on the BLUE Proxy Card
• Vote Today! For questions or help with voting, call 1-888-518-6813 (toll free in North America), text or call 437-561-5012, email [email protected] or visit www.futureofgildan.com

MONTREAL, May 13, 2024 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL; TSX and NYSE) today announced that it has published an investor... (continue reading...)

Will Lead Brennan's 17 Regional Offices

ROSEMONT, Ill. , May 13, 2024 /PRNewswire/ -- Brennan Investment Group ("Brennan"), a leading private real estate investment firm specializing in the acquisition, development, and operation of industrial facilities across the United States, announced the promotion of Kevin Brennan to Chief Investment Officer. With this appointment, Kevin will lead Brennan's 17 regional offices in its objective of investing in value-add... (continue reading...)

ALPHARETTA, Ga., May 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Sigfrido (Sig) Delgado has been appointed senior vice president, integrated supply chain. In this role, Delgado will lead the teams focused on implementing continuous improvements within the Company's end-to-end supply chain capabilities worldwide.

Company Declares Quarterly Dividend of $0.17 Per Share

LAS VEGAS--(BUSINESS WIRE)-- Boyd Gaming Corporation (NYSE: BYD) today announced that its Board of Directors has authorized an additional $500 million under the Company’s share repurchase program.

Considering the additional authorization, the Company had approximately $721 million remaining in repurchase authority as of March 31, 2024.

Additionally, the Board of Directors has declared a quarterly cash... (continue reading...)